foxo4 dri for senescent cells

foxo4 dri for senescent cells FOXO4-DRI Peptide Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4 dri for senescent cells FOXO4-DRI Peptide Peptide inhibitors targeting FOXO4-p53 interactions
Brand: creatorsinfotech.com
SKU: 5970980060
Price: 21.36 USD
Availability: InStock
Rating: 4.5364 (30 reviews)

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs foxo4 dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4 DRI Peptide for Cellular FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology

SKU: 5970980060 · From creatorsinfotech.com

4.5

USD21.36 USD65.36

Pay in 4 interest-free payments of $5.34 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 26 - Oct 31

Description

Polter et al., 2014

BPC-157 Description BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide (a pentadecapeptide) derived from a partial sequence of a protective protein found in human gastric juice, first isolated and characterized at the University of Zagreb in the early 1990s

Fat Metabolism & Liver Protection Methionine facilitates: Hepatic lipoprotein synthesis Prevention of fat accumulation in the liver (lipotropic effect) Detoxification via methylation and trans-sulfuration pathways E

Lactated Ringers solution was provided intravenously at 10 mL kg per hour throughout anesthesia

In cases of severe and hemodynamically unstable hypothermia, transport to an ECLS capable facility will further improve the patients chances for survival.